lapatinib has been researched along with Pregnancy in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asselain, B; Barraud, S; Bihan, K; Coussy, F; Dumas, E; Gougis, P; Grandal, B; Hamy, AS; Hotton, J; Jochum, F; Laas, E; Pierga, JY; Reyal, F; Savarino, R; Sebbag, C; Spaggiari, E; Spano, JP | 1 |
| Ai, J; Chen, G; Chen, J; Feng, X; Li, K; Li, X; Liao, Q; Yang, B | 1 |
| Azim, HA; Baselga, J; Campbell, C; de Azambuja, E; Di Cosimo, S; Gelber, RD; Guillaume, S; Hilbers, FS; Huober, J; Ignatiadis, M; Korde, L; Lambertini, M; Martel, S; Moreno-Aspitia, A; Piccart-Gebhart, M; Schuehly, U; Tenglin, RC | 1 |
| Bines, J; Tevaarwerk, AJ | 1 |
| Broutin, S; Gil, S; Jovelet, C; Mir, O; Paci, A | 1 |
| De Keulenaer, GW; Doggen, K; Lemmens, K | 1 |
| Evens, A; Osborne, CK | 1 |
| Boggess, KA; Dees, EC; Dorflinger, LJ; Graham, M; Harris, J; Humes, E; Kelly, H; O'Neil, BH; Spector, NL | 1 |
| Berveiller, P; Goffinet, F; Goldwasser, F; Mir, O; Pons, G; Ropert, S; Treluyer, JM | 1 |
| Blumenfeld, M; Farrar, W; Landon, MB; Pant, S; Shapiro, CL | 1 |
2 review(s) available for lapatinib and Pregnancy
| Article | Year |
|---|---|
[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Agents; Dasatinib; Erlotinib Hydrochloride; Female; Fetus; Gefitinib; Humans; Imatinib Mesylate; Lapatinib; Maternal Age; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk | 2016 |
Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Lapatinib; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab; Vinblastine; Vinorelbine | 2008 |
1 trial(s) available for lapatinib and Pregnancy
| Article | Year |
|---|---|
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Lapatinib; Neoadjuvant Therapy; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Receptor, ErbB-2; Trastuzumab | 2019 |
7 other study(ies) available for lapatinib and Pregnancy
| Article | Year |
|---|---|
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
Topics: Ado-Trastuzumab Emtansine; Adult; Antineoplastic Agents; Breast Neoplasms; Case-Control Studies; Female; Humans; Infant, Newborn; Lapatinib; Pregnancy; Receptor, ErbB-2; Trastuzumab | 2023 |
Lapatinib‑induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro.
Topics: Animals; ErbB Receptors; Female; Fertility; Lapatinib; Male; Mice; Mice, Inbred C57BL; Oocytes; Ovarian Follicle; Ovarian Reserve; Ovary; Phosphorylation; Pregnancy; Protein Kinase Inhibitors; Random Allocation; Signal Transduction; STAT3 Transcription Factor; Tissue Culture Techniques | 2020 |
Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
Topics: Breast Neoplasms; Female; Humans; Lapatinib; Pregnancy; Pregnancy Outcome; Receptor, ErbB-2; Trastuzumab | 2019 |
Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy.
Topics: Animals; Female; Genes, erbB; Lapatinib; Mice; Mice, Inbred C57BL; Neuregulin-1; Phosphorylation; Pregnancy; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Humans; Lapatinib; Lymphoma; Molecular Targeted Therapy; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Receptor, ErbB-2; Rituximab; Trastuzumab; Vinblastine; Vincristine | 2011 |
Delivery of a healthy baby after first-trimester maternal exposure to lapatinib.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Infant, Newborn; Lapatinib; Live Birth; Neoplasm Metastasis; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Quinazolines | 2006 |
Treatment of breast cancer with trastuzumab during pregnancy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorouracil; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Lapatinib; Lung Neoplasms; Mastectomy, Modified Radical; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Trastuzumab | 2008 |